These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 3156702
1. Activated T cells in Graves' disease before treatment. Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D. Clin Exp Immunol; 1985 Feb; 59(2):377-82. PubMed ID: 3156702 [Abstract] [Full Text] [Related]
2. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells. Karlsson FA, Tötterman TH. Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281 [Abstract] [Full Text] [Related]
3. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism. Gerstein HC, Rastogi B, Iwatani Y, Iitaka M, Row VV, Volpé R. Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555 [Abstract] [Full Text] [Related]
4. Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease. Charreire J, Karsenty G, Bouchard P, Schaison G. Clin Exp Immunol; 1984 Sep; 57(3):633-8. PubMed ID: 6147216 [Abstract] [Full Text] [Related]
5. Immunohistological phenotyping of thyroid infiltrating lymphocytes in Graves' disease and Hashimoto's thyroiditis. Misaki T, Konishi J, Nakashima T, Iida Y, Kasagi K, Endo K, Uchiyama T, Kuma K, Torizuka K. Clin Exp Immunol; 1985 Apr; 60(1):104-10. PubMed ID: 3891164 [Abstract] [Full Text] [Related]
6. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease. Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H, Matsunaga M, Kawabe Y, Shimomura C, Izumi M. J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751 [Abstract] [Full Text] [Related]
7. Heterogeneity of immunoregulatory T cells in human thyroid autoimmunity: influence of thyroid status. Bonnyns M, Bentin J, Devetter G, Duchateau J. Clin Exp Immunol; 1983 Jun; 52(3):629-34. PubMed ID: 6223729 [Abstract] [Full Text] [Related]
8. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Jansson R, Karlsson A, Forsum U. Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731 [Abstract] [Full Text] [Related]
9. Humoral and cellular immunological factors as possible markers of clinical relapse in HLA-typed Graves' patients followed with time. Di Mario U, Vitillo M, Perfetti R, Mancuso M, Morellini M, Cappellacci S, Pozzilli P, Andreani D. Horm Metab Res; 1989 May; 21(5):267-71. PubMed ID: 2789166 [Abstract] [Full Text] [Related]
10. Studies on peripheral T lymphocyte subsets in patients with autoimmune thyroid diseases. Chen G, Zhang KZ, Liao ZH, Wang SH, Ma SJ, Long ZZ, Tian WT, Zhu JY. Chin Med J (Engl); 1989 Sep; 102(9):698-701. PubMed ID: 2534289 [Abstract] [Full Text] [Related]
11. The remarkable proliferation of helper T cell subset in response to autologous thyrocytes and intrathyroidal T cells from patients with Graves' disease. Eguchi K, Otsubo T, Kawabe Y, Ueki Y, Fukuda T, Matsunaga M, Shimomura C, Ishikawa N, Tezuka H, Nakao H. Clin Exp Immunol; 1987 Nov; 70(2):403-10. PubMed ID: 2962792 [Abstract] [Full Text] [Related]
12. Increase of peripheral B lymphocytes in Graves' disease. Mori H, Amino N, Iwatani Y, Kabutomori O, Asari S, Motoi S, Miyai K, Kumahara Y. Clin Exp Immunol; 1980 Oct; 42(1):33-40. PubMed ID: 6970099 [Abstract] [Full Text] [Related]
13. Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Warford A, McLachlan SM, Malcolm AJ, Young ET, Farndon JR, Rees Smith B. Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996 [Abstract] [Full Text] [Related]
14. Lymphocyte subsets and specific T-cell immune response in thalassemia. Pattanapanyasat K, Thepthai C, Lamchiagdhase P, Lerdwana S, Tachavanich K, Thanomsuk P, Wanachiwanawin W, Fucharoen S, Darden JM. Cytometry; 2000 Feb 15; 42(1):11-7. PubMed ID: 10679738 [Abstract] [Full Text] [Related]
15. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. Colucci G, Colombo M, Del Ninno E, Paronetto F. Gastroenterology; 1983 Nov 15; 85(5):1138-45. PubMed ID: 6225691 [Abstract] [Full Text] [Related]
16. Characterization of T lymphocyte subsets with monoclonal antibodies: discovery of a distinct marker, Ly-m22, of T suppressor cells. Chan MM, Tada N, Kimura S, Hoffmann MK, Miller RA, Stutman O, Hämmerling U. J Immunol; 1983 May 15; 130(5):2075-8. PubMed ID: 6187835 [Abstract] [Full Text] [Related]
18. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial. Brennan PC, Graham MA, Triano JJ, Hondras MA, Anderson RJ. J Manipulative Physiol Ther; 1994 May 15; 17(4):219-27. PubMed ID: 8046277 [Abstract] [Full Text] [Related]
19. Analysis of peripheral T lymphocyte subpopulations in Graves' disease. Okabe N, Inoue K, Mori R. J Clin Lab Immunol; 1983 Feb 15; 10(2):91-5. PubMed ID: 6221106 [Abstract] [Full Text] [Related]
20. Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. Lobo-Yeo A, Alviggi L, Mieli-Vergani G, Portmann B, Mowat AP, Vergani D. Clin Exp Immunol; 1987 Jan 15; 67(1):95-104. PubMed ID: 2957133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]